Personal Experience with Corynebacterium Parvum in Human Cancers

Overview

Journal World J Surg

Publisher Wiley

Specialty General Surgery

Date 1977 Sep 1

PMID 602233

Citations 5

Authors

L Israel

R Edelstein

Affiliations

Soon will be listed here.

Citing Articles

A randomized study of combination chemotherapy (VAC-FMC) with or without immunostimulation by Corynebacterium parvum in metastatic breast cancer.

Fritze D, Becher R, Massner B, Kaufmann M, Bruntsch U, Gallmeier W Klin Wochenschr. 1982; 60(12):593-8.

PMID: 7109499 DOI: 10.1007/BF01711434.

Hypercoagulability after immunotherapy with Corynebacterium parvum in man.

Harenberg J, Baumgartner A, Fritze D, Zimmermann R Blut. 1982; 44(4):241-7.

PMID: 7082858 DOI: 10.1007/BF00319910.

Adjuvant therapy in colorectal cancer.

House A J R Soc Med. 1984; 77(6):445-50.

PMID: 6737402 PMC: 1439811. DOI: 10.1177/014107688407700601.

Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum.

Fritze D, Massner B, Becher R, Kaufmann M, Illiger H, Hartlapp J Klin Wochenschr. 1984; 62(4):162-7.

PMID: 6368960 DOI: 10.1007/BF01731638.

Corynebacterium parvum enhances colonic cancer in dimethylhydrazine-treated rats.

Cruse J, Lewin M, Clark C Br J Cancer. 1978; 37(4):639-43.

PMID: 646934 PMC: 2009549. DOI: 10.1038/bjc.1978.94.

References

Israel L . Non-specific immunostimulation in bronchogenic cancer. Scand J Respir Dis Suppl. 1974; 89:95-105. View

Israel L, Edelstein R, Depierre A, Dimitrov N . Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: a preliminary report of clinical and biologic findings. J Natl Cancer Inst. 1975; 55(1):29-33. DOI: 10.1093/jnci/55.1.29. View

CURRIE G, Eccles S . Serum lysozyme as a marker of host resistance. I. Production by macrophages resident in rat sarcomata. Br J Cancer. 1976; 33(1):51-9. PMC: 2024922. DOI: 10.1038/bjc.1976.6. View

Korontzis M, Jolles P . Hydrosoluble immunopotentiating substances extraced from Corynebacterium parvum. Immunol Commun. 1974; 3(6):593-603. DOI: 10.3109/08820137409061137. View

Biran H, Moake J, Reed R, Gutterman J, Hersh E, Freireich E . Complement activation in vivo in cancer patients receiving C. parvum immunotherapy. Br J Cancer. 1976; 34(5):493-9. PMC: 2025195. DOI: 10.1038/bjc.1976.203. View

Hersh E, Whitecar Jr J, McCredie K, Bodey Sr G, Freireich E . Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N Engl J Med. 1971; 285(22):1211-6. DOI: 10.1056/NEJM197111252852201. View

Israel L, Halpern B . [Corynebacterium parvum in advanced cancers. 1st evaluation of the therapeutic activity of this immunostimulin]. Nouv Presse Med. 1972; 1(1):19-23. View

Israel L, Mannoni P, Radot E, GREENSPAN E . [Letter: Immune and tumor reactions to plasma exchange in advanced cancers]. Nouv Presse Med. 1976; 5(7):433. View

Israel L, Edelstein R, Mannoni P, Radot E . Plasmapheresis and immunological control of cancer. Lancet. 1976; 2(7986):642-3. DOI: 10.1016/s0140-6736(76)90721-2. View

10.

PEARSON J, Pearson G, Gibson W, Chermann J, Chirigos M . Combined chemoimmunostimulation therapy against murine leukemia. Cancer Res. 1972; 32(5):904-7. View

11.

HALPERN B, BIOZZI G, STIFFEL C, Mouton D . Inhibition of tumour growth by administration of killed corynebacterium parvum. Nature. 1966; 212(5064):853-4. DOI: 10.1038/212853a0. View

12.

Woodruff M, BOAK J . Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts. Br J Cancer. 1966; 20(2):345-55. PMC: 2008959. DOI: 10.1038/bjc.1966.42. View

13.

Wolmark N, Fisher B . The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice. Cancer Res. 1974; 34(11):2869-72. View

14.

Band P, Urtasun R, Haraphongse M . Phase I study of corynebacterium parvum in patients with solid tumors. Cancer Chemother Rep. 1975; 59(6):1139-45. View

15.

Fisher B, Wolmark N, Saffer E, Fisher E . Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors. Cancer. 1975; 35(1):134-43. DOI: 10.1002/1097-0142(197501)35:1<134::aid-cncr2820350119>3.0.co;2-g. View